Abstract
e18209 Background: Although clear guidelines for BC management have been developed and widespread, there are many variations between centers, with impact in clinical outcomes. Quality indicators to assess care allows comparison with standards and monitoring changes post intervention. The objective is to evaluate quality indicators in BC care at our Breast Unit. Methods: Retrospective analysis of women diagnosed and treated for BC from June 2014 through June 2016 .The European Society of Mastology (EUSOMA) guidelines for quality assurance in BC and diagnosis (published in 2010 and up dated in 2013 ) were used in order to asses quality of care Results: 103 patients treated for BC were included in the study. Median age was 54 years old, ductal carcinoma: 76,5 %, histological grade I-II: 74 %; stage 0-II: 72%, axillary metastasis: 39 %, progesterone receptor/estrogen receptors+ (RE/RP+): 64 %, HER2+: 27 %. Quality criteria associated to preoperative diagnosis, pathology analysis, surgical treatment, radiotherapy and oncologic treatment were met. Conclusions: Quality indicators allows BC evaluation from established standards, giving objective and reproducible information, helpful to plan process optimization. Care received by patients seen at the Hospital de Clinicas BC Unit during the referred period met all indicators suggested by the European Society of Mastology. [Table: see text]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have